Home LiteratureArticle Details
PMID: 16415008 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Journal of virology ·Vol. 80 ·No. 3 ·2006-02-00 ·Pages 1311-20

O'Neill E, Kuo LS, Krisko JF, Tomchick DR, Garcia JV, Foster JL

Abstract

The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nef's PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

MeSH Terms
Amino Acid Sequence Amino Acid Substitution Cell Line Conserved Sequence Databases, Protein Enzyme Activation Evolution, Molecular Gene Products, nef/chemistry,genetics,physiology HIV-1/classification,genetics,pathogenicity,physiology HeLa Cells Humans In Vitro Techniques Mutagenesis, Site-Directed Protein Serine-Threonine Kinases/metabolism Protein Structure, Tertiary Recombinant Proteins/chemistry,genetics,metabolism Virulence/genetics,physiology nef Gene Products, Human Immunodeficiency Virus p21-Activated Kinases
Chemicals
Gene Products, nef Recombinant Proteins nef Gene Products, Human Immunodeficiency Virus PAK2 protein, human Protein Serine-Threonine Kinases p21-Activated Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
O'Neill Eduardo
Department of Internal Medicine, Division of Infectious Diseases Y9.206, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9113, USA.
Kuo Lillian S
Krisko John F
Tomchick Diana R
Garcia J Victor
Foster John L
References (55)
55 references, click to expand
  1. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques.
    Curr Biol. 1996 Nov 1;6(11):1519-27 PMID: 8939608
  2. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity.
    J Biol Chem. 1995 Jun 23;270(25):15307-14 PMID: 7797518
  3. Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation.
    Virology. 1996 Mar 1;217(1):293-300 PMID: 8599214
  4. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.
    Virology. 1996 Oct 1;224(1):292-301 PMID: 8862424
  5. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.
    EMBO J. 1997 Feb 17;16(4):673-84 PMID: 9049297
  6. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase.
    Immunity. 1997 Mar;6(3):283-91 PMID: 9075929
  7. Refined solution structure and backbone dynamics of HIV-1 Nef.
    Protein Sci. 1997 Jun;6(6):1248-63 PMID: 9194185
  8. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques.
    Nat Med. 1997 Aug;3(8):860-5 PMID: 9256276
  9. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
    Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 PMID: 9254694
  10. Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase.
    J Virol. 1997 Dec;71(12):9524-30 PMID: 9371615
  11. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic.
    Nature. 1998 Feb 5;391(6667):594-7 PMID: 9468138
  12. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.
    EMBO J. 1998 May 15;17(10):2777-89 PMID: 9582271
  13. Limitations of a molecular clock applied to considerations of the origin of HIV-1.
    Science. 1998 Jun 19;280(5371):1868-71 PMID: 9669945
  14. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase.
    Virology. 1998 Oct 25;250(2):273-82 PMID: 9792838
  15. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes.
    Cell. 1999 Apr 2;97(1):63-73 PMID: 10199403
  16. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.
    J Virol. 1999 Jul;73(7):5497-508 PMID: 10364298
  17. Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection.
    Virology. 1999 Jul 5;259(2):349-68 PMID: 10388660
  18. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions.
    Mol Cell. 1999 Jun;3(6):729-39 PMID: 10394361
  19. Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.
    Virology. 1999 Sep 15;262(1):55-63 PMID: 10489340
  20. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts.
    J Virol. 2004 Dec;78(23):12773-80 PMID: 15542629
  21. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2.
    J Virol. 2005 Jan;79(1):632-6 PMID: 15596859
  22. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.
    J Virol. 2000 Mar;74(6):2907-12 PMID: 10684310
  23. Interactions of HIV-1 NEF with cellular signal transducing proteins.
    Front Biosci. 2000 Feb 1;5:D268-83 PMID: 10704155
  24. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.
    Nat Cell Biol. 2000 Mar;2(3):163-7 PMID: 10707087
  25. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions.
    J Virol. 2000 Jun;74(11):5310-9 PMID: 10799608
  26. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
    J Virol. 2000 Jun;74(12):5691-701 PMID: 10823877
  27. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.
    Protein Sci. 2000 Jun;9(6):1137-48 PMID: 10892807
  28. The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation.
    J Biol Chem. 2000 Jul 28;275(30):23097-105 PMID: 10807905
  29. Lentivirus Nef specifically activates Pak2.
    J Virol. 2000 Dec;74(23):11081-7 PMID: 11070003
  30. Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors.
    AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1855-68 PMID: 11118071
  31. Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.
    J Virol. 2001 Feb;75(4):1672-80 PMID: 11160665
  32. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
    J Virol. 2001 Apr;75(8):3657-65 PMID: 11264355
  33. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP.
    J Virol. 2001 Apr;75(8):3971-6 PMID: 11264386
  34. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell.
    Nature. 2001 Apr 12;410(6830):834-8 PMID: 11298454
  35. Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein.
    Trends Biochem Sci. 2001 Jun;26(6):356-63 PMID: 11406408
  36. Structure--function relationships in HIV-1 Nef.
    EMBO Rep. 2001 Jul;2(7):580-5 PMID: 11463741
  37. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals.
    Nat Med. 2001 Nov;7(11):1217-24 PMID: 11689886
  38. Evolutionary and immunological implications of contemporary HIV-1 variation.
    Br Med Bull. 2001;58:19-42 PMID: 11714622
  39. Nef: agent of cell subversion.
    Microbes Infect. 2002 Feb;4(2):189-99 PMID: 11880052
  40. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
    J Virol. 2002 Jun;76(11):5435-51 PMID: 11991972
  41. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.
    Cell. 2002 Dec 13;111(6):853-66 PMID: 12526811
  42. Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development.
    Blood. 2003 Oct 15;102(8):2925-32 PMID: 12855553
  43. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
    AIDS. 2003 Dec 5;17(18):2547-60 PMID: 14685049
  44. HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane.
    Mol Cell. 2004 Jan 30;13(2):179-90 PMID: 14759364
  45. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis.
    PLoS Biol. 2004 Jan;2(1):E6 PMID: 14737186
  46. The brightening future of HIV therapeutics.
    Nat Immunol. 2004 Sep;5(9):867-71 PMID: 15334078
  47. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
    Nature. 1991 Apr 11;350(6318):508-11 PMID: 2014052
  48. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
    J Virol. 1991 Aug;65(8):3973-85 PMID: 1830110
  49. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
    Proteins. 1991;11(4):281-96 PMID: 1758883
  50. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    J Virol. 1992 Apr;66(4):2232-9 PMID: 1548759
  51. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS.
    Virology. 1992 Jun;188(2):811-8 PMID: 1350126
  52. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.
    J Virol. 1993 Aug;67(8):4639-50 PMID: 8043040
  53. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1539-43 PMID: 8108442
  54. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection.
    J Virol. 1995 Jan;69(1):93-100 PMID: 7983771
  55. Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.
    J Virol. 1995 Nov;69(11):6758-69 PMID: 7474087
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-02-00
Pages
1311-20
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1346962
Subset
IM
Grants
NIAID NIH HHS · R01 AI033331 · United States
NIAID NIH HHS · AI 33331 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com